Bayer Stock
Investor Information
In the third quarter of 2008 the stock market was dominated by the effects of the international financial crisis, with the DAX down nearly 8 percent on the period. In this volatile environment, Bayer stock largely held its own, moving more or less laterally (–1.6 percent). The relative strength of our stock was also evident over the nine-month period. Although Bayer stock closed at €51.80 on September 30, 2008, down 17.2 percent from the end of 2007, giving a performance of minus 15.1 percent, the DAX lost 27.7 percent in the same period, closing at 5,831 points. The European reference index EURO STOXX 50 suffered comparably heavy losses, closing the third quarter at 4,615 points, down 28.4 percent from the beginning of the year.
With effect from September 22, 2008, Bayer stock is included in the Dow Jones STOXX 50, a European blue chip index comprising the top 50 stocks from 17 western European countries.
At the end of September, Bayer hosted the “Meet Management” conference in Leverkusen for the third time. Some 90 investors and analysts accepted the company’s invitation to participate in group discussions with members of the management boards of Bayer AG and the subgroups. These talks focused on corporate strategy, developments in key markets, the effects of the financial crisis and the candidates in the pharmaceutical research pipeline.
With effect from September 22, 2008, Bayer stock is included in the Dow Jones STOXX 50, a European blue chip index comprising the top 50 stocks from 17 western European countries.
At the end of September, Bayer hosted the “Meet Management” conference in Leverkusen for the third time. Some 90 investors and analysts accepted the company’s invitation to participate in group discussions with members of the management boards of Bayer AG and the subgroups. These talks focused on corporate strategy, developments in key markets, the effects of the financial crisis and the candidates in the pharmaceutical research pipeline.
| Bayer Stock Key Data | 3rd Quarter 2007 | 3rd Quarter 2008 | First Nine Months 2007 | First Nine Months 2008 | |
| High for the period | € | 58.56 | 57.53 | 58.56 | 65.68 |
| Low for the period | € | 50.33 | 51.80 | 40.20 | 45.90 |
| Average daily share turnover on German stock exchanges | million | 6.0 | 4.9 | 5.9 | 5.5 |
| Sept. 30, 2007 | Sept. 30, 2008 | Dec. 31, 2007 | Change Sept. 30, 2008/ Dec. 31, 2007 % | ||
| Share price | € | 55.82 | 51.80 | 62.53 | -17.2 |
| Market capitalization | € million | 42,665 | 39,593 | 47,794 | -17.2 |
| Stockholders’ equity as per balance sheets | € million | 17,008 | 18,310 | 16,821 | +8.9 |
| Number of shares entitled to the dividend | million | 764.34 | 764.34 | 764.34 | 0.0 |
| DAX | 7,862 | 5,831 | 8,067 | -27.7 |
XETRA closing prices; source: Bloomberg
Performance over the Past Twelve Months
(indexed; 100 = Xetra closing price on September 30, 2007)

Earnings per share according to IFRS are affected by the purchase price allocation for Schering, Berlin, Germany, and other special factors. To enhance comparability, we also determine core net income from continuing operations after elimination of the amortization of intangible assets, asset write-downs (including any impairment losses), special items in EBITDA including the related tax effects, and one-time tax income or expense.
The calculation of earnings per share in accordance with the International Financial Reporting Standards (IFRS) is explained in the notes to the consolidated financial statements. Adjusted core net income, core earnings per share and core EBIT are not defined in the IFRS. Therefore they should be regarded as supplementary information rather than stand-alone indicators.
The calculation of earnings per share in accordance with the International Financial Reporting Standards (IFRS) is explained in the notes to the consolidated financial statements. Adjusted core net income, core earnings per share and core EBIT are not defined in the IFRS. Therefore they should be regarded as supplementary information rather than stand-alone indicators.
| Calculation of Core EBIT and Core Earnings per Share | 3rd Quarter 2007 | 3rd Quarter 2008 | First Nine Months 2007 | First Nine Months 2008 |
| € million | ||||
| EBIT as per income statement | 677 | 684 | 2,769 | 3,132 |
| Amortization and write-downs of intangible assets | 479 | 385 | 1,097 | 1,170 |
| Write-downs of property, plant and equipment | 9 | 3 | 86 | 63 |
| Special items (other than write-downs) | 120 | 159 | 570 | 411 |
| Core EBIT | 1,285 | 1,231 | 4,522 | 4,776 |
| Non-operating result (as per income statement) | (266) | (276) | (741) | (813) |
| Income taxes (as per income statement) | 769 | (133) | 221 | (701) |
| One-time tax income* | (911) | 0 | (911) | 0 |
| Tax adjustment | (234) | (151) | (617) | (484) |
| Income after taxes attributable to minority interest (as per income statement) | (3) | (1) | (1) | (8) |
| Core net income from continuing operations | 640 | 670 | 2,473 | 2,770 |
| Financing expenses for the mandatory convertible bond, net of tax effects | 25 | 28 | 73 | 84 |
| Adjusted core net income | 665 | 698 | 2,546 | 2,854 |
| Shares | ||||
| Weighted average number of issued ordinary shares | 764,341,920 | 764,341,920 | 764,341,920 | 764,341,920 |
| Potential shares to be issued upon conversion of the mandatory convertible bond | 59,585,493 | 60,040,823 | 59,558,606 | 59,843,529 |
| Adjusted weighted average total number of issued and potential ordinary shares | 823,927,413 | 824,382,743 | 823,900,526 | 824,185,449 |
| Core earnings per share from continuing operations (€) | 0.81 | 0.85 | 3.09 | 3.46 |
* arising from the corporate tax reform in Germany

Overview of Sales, Earnings and Financial Position
Bayer Links
Investor Relations

Bookmark this page
E-mail this page
Advanced Search

